Exercise or conversion
Andrew Reardon
CLO & Secretary
Common Stock
- Value context
- $17.77K
- Reported price
- $52.27 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
LIGAND PHARMACEUTICALS INC
Last 30 daysNo qualifying insider buying. Sales: $3.29M by 2 insiders.
Showing the first 6 of 20 trades on this page.
CLO & Secretary
Common Stock
CLO & Secretary
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Non-Qualified Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Non-Qualified Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Non-Qualified Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Non-Qualified Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CLO & Secretary
Common Stock
CLO & Secretary
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
CLO & Secretary
Common Stock
CLO & Secretary
Common Stock
CLO & Secretary
Employee Stock Option (right to buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CLO & Secretary | Common StockOption exercise or conversion10b5-1 | 340$52.27 / share | $17.77K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| CLO & Secretary | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units340$52.27 exercise / conversion price | Not a separate purchase | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockExercise-price or tax withholding | 115$298.50 / share | $34.33K | Sep 22Filed Sep 24 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 16,179$52.84 / share | $854.9K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 2,074$70.04 / share | $145.26K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 2,869$55.75 / share | $159.95K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 7,171$57.22 / share | $410.32K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 3,348$68.74 / share | $230.14K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units2,869$55.75 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units7,171$57.22 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Non-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units16,179$52.84 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Non-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units3,348$68.74 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Chief Financial Officer | Non-Qualified Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units2,074$70.04 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 6,138$51.56 / share | $316.48K | Aug 12Filed Aug 14 · 2d later | SEC filing |
| Director | Non-Qualified Stock Option (right to buy)Option exercise or conversion | Derivative units6,138$51.56 exercise / conversion price | Not a separate purchase | Aug 12Filed Aug 14 · 2d later | SEC filing |
| CLO & Secretary | Common StockOption exercise or conversion10b5-1 | 5,000$52.27 / share | $261.35K | Aug 3Filed Aug 4 · 1d later | SEC filing |
| CLO & Secretary | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units5,000$52.27 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 4 · 1d later | SEC filing |
| CLO & Secretary | Common StockOther transaction10b5-1 | 132$160.71 / share | $21.21K | Jun 30Filed Jul 6 · 6d later | SEC filing |
| CLO & Secretary | Common StockOption exercise or conversion10b5-1 | 5,000$52.27 / share | $261.35K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| CLO & Secretary | Employee Stock Option (right to buy)Option exercise or conversion10b5-1 | Derivative units5,000$52.27 exercise / conversion price | Not a separate purchase | Jul 1Filed Jul 6 · 5d later | SEC filing |
Showing the latest 20 of 65 trades. Show all 65 trades
Ligand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberLigand Pharmaceuticals Incorporated - Common Stock (LGND) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.